Literature DB >> 31152677

Low concordance between HbA1c and OGTT to diagnose prediabetes and diabetes in overweight or obesity.

Kyriazoula Chatzianagnostou1, Luisella Vigna2, Silvana Di Piazza2, Amedea Silvia Tirelli3, Filomena Napolitano3, Laura Tomaino4, Fabrizia Bamonti5, Irene Traghella1, Cristina Vassalle1.   

Abstract

BACKGROUND: Glycated haemoglobin (HbA1c) test, introduced for diagnosing prediabetes and diabetes by the American Diabetes Association for some years, is currently under extensive discussion for contradictory data on the concordance between this test and the oral glucose tolerance test (OGTT). HYPOTHESIS: To assess concordance between HbA1c and OGTT to diagnose prediabetes and diabetes in subjects with overweight or obesity, focusing on possible gender-related differences.
METHODS: A total of 949 outpatients with overweight or obesity at risk for diabetes (mean age 50 ± 15 years; 660 F) were enrolled and underwent HbA1c test and OGTT.
RESULTS: In both genders, HbA1c test identified more patients with prediabetes than OGTT (42% vs 22% in males, 40% vs 18% in females, respectively): a slight concordance between HbA1c and OGTT (60% of total tests in both genders). In subjects diagnosed by OGTT, post-OGTT insulin levels and HOMA INDEX were significantly higher than those found in HbA1c(+) cases. Instead, those diagnosed with HbA1c were significantly older and showed higher uric acid than those with both tests (-).
CONCLUSIONS: HbA1c test and OGTT did not reach full concordance for the diagnosis of diabetes and prediabetes in both genders. The two tests likely reflect different physiopathological aspects of dysglycaemia, suggesting that the 'diagnostic thresholds' could be reconsidered in light of the discordance observed.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  HbA1c; OGTT; gender; obesity; overweight; prediabetes; type 2 diabetes

Year:  2019        PMID: 31152677     DOI: 10.1111/cen.14043

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  5 in total

Review 1.  Polycystic ovary syndrome and type 2 diabetes mellitus: A state-of-the-art review.

Authors:  Sarantis Livadas; Panagiotis Anagnostis; Julia K Bosdou; Dimitra Bantouna; Rodis Paparodis
Journal:  World J Diabetes       Date:  2022-01-15

2.  Can dysglycemia in OGTT be predicted by baseline parameters in patients with PCOS?

Authors:  Sarantis Livadas; Christina Bothou; Justyna Kuliczkowska-Płaksej; Ralitsa Robeva; Andromahi Vryonidou; Jelica Bjekic Macut; Ioannis Androulakis; Milica Opalic; Zadalla Mouslech; Andrej Milewicz; Alessandra Gambineri; Dimitrios Panidis; Djuro Macut
Journal:  Endocr Connect       Date:  2022-04-22       Impact factor: 3.221

Review 3.  The Oral Glucose Tolerance Test: 100 Years Later.

Authors:  Ram Jagannathan; João Sérgio Neves; Brenda Dorcely; Stephanie T Chung; Kosuke Tamura; Mary Rhee; Michael Bergman
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-19       Impact factor: 3.168

4.  A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.

Authors:  Xintian Cai; Qing Zhu; Yuanyuan Cao; Shasha Liu; Mengru Wang; Ting Wu; Jing Hong; Ayguzal Ahmat; Xiayire Aierken; Nanfang Li
Journal:  Biomed Res Int       Date:  2021-05-14       Impact factor: 3.411

5.  Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c.

Authors:  Stelios Karayiannides; Catarina Djupsjö; Jeanette Kuhl; Claes Hofman-Bang; Anna Norhammar; Martin J Holzmann; Pia Lundman
Journal:  Cardiovasc Diabetol       Date:  2021-06-14       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.